Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at imatinib for melanoma of the eye that has spread (ITEM)

Overview

Cancer types:

Eye cancer, Melanoma, Melanoma of the eye, Secondary cancers

Status:

Results

Phase:

Phase 2

Details

This trial looked at imatinib (Glivec) for a type of melanoma of the eye (uveal melanoma) that had spread to another part of the body and couldn’t be removed with an operation. This is called advanced melanoma of the eye. This trial was for people whose melanoma cells, had a large amount of a protein called c-kit.

This trial was supported by Cancer Research UK.

Recruitment start: 19 August 2008

Recruitment end: 7 January 2010

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Ernie Marshall

Supported by

Cancer Research UK

Clatterbridge Cancer Centre NHS Foundation Trust

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUK/07/042.

Last reviewed: 26 Sept 2013

CRUK internal database number: 2432

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.